Canakinumab Relieves Symptoms In Systemic Juvenile Idiopathic Arthritis - Medical New

[INCIID News Feed]

Reuters
<img alt="" height="1" width="1" />
Canakinumab Relieves Symptoms In Systemic Juvenile Idiopathic Arthritis
Medical News Today
Canakinumab (ACZ885; Novartis) achieves major relief of symptoms in patients with systemic juvenile idiopathic arthritis (SJIA), according to encouraging results from a pivotal phase III trial with the anti-interleukin-1 beta antibody reported at the ...
Novartis drug helps in serious childhood arthritisReuters
Novartis announces arthritis drug study resultsBusinessWeek
Novartis Study Shows Ilaris Helps Children With Rare Childhood ArthritisRTT News
Bloomberg -Proactive Investors USA & Canada -ThirdAge
all 42 news articles &raquo;


More...